A New Target in Cancer Treatment: Carbon Monoxide

Carbon monoxide (CO) is a toxic gas and also a signaling molecule used between cells. Some studies suggest that CO may have potential effects against breast cancer. However, only a limited amount of information is available concerning its effects on humans.
Breast Cancer and Carbon Monoxide Poisoning
In October 2020, Scientific Reports published a study assessing the relationship between CO and breast cancer risk using a list of women who experienced CO poisoning between 2002 and 2009 in Taiwan's National Poisoning Database. Comparing 7,053 women followed through 2014 with 42,318 women who had not experienced CO poisoning showed a lower breast cancer risk in the poisoning group (0.7% versus 1.0%). The 0.3% difference was statistically significant.
After considering factors such as age, monthly income, geographical location, hypertension, diabetes and hyperlipidemia, the researchers suggested that CO poisoning might have a potentially protective effect against breast cancer in humans. This certainly must not be interpreted to mean that CO poisoning could be used to prevent or treat cancer; rather, it suggests that the cellular CO signaling pathway might be a potential treatment target. This may be worth investigating. Reduced breast cancer risk after CO exposure may be attributable to its direct toxic effect and the death of cancer cells due to severe hypoxia (low oxygen).
However, the study has limitations: it could not include factors such as family history, reproductive history, physical activity and body mass index; it had no male participants, given that breast cancer is rare in men; participants were relatively young (mean age 34); and it did not compare breast cancer stage or ER/PR/HER2 status between those with and without CO poisoning, or assess survival. More research is therefore needed, as no clear conclusion can be drawn on this topic.
Summary of Other Studies on the Relationship Between Cancer and Carbon Monoxide
- CO gas was used in mice given human pancreatic cancer cells beneath the skin. Exposure to CO was observed to substantially inhibit the proliferation of human pancreatic cancer cells and double the mice's survival rates.
- Another animal study examined low-dose CO's effect on the tumor microenvironment and reported that it inhibited lung cancer progression by modulating myeloid cell/macrophage infiltration and phenotype. Induction of apoptosis in lung tumors was associated with CD86 expression and activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway.
- A laboratory study found that inhaling CO could increase tumor hypoxia in a way that might affect tumor control. Although hypoxia can contribute to tumor progression, a severe acute hypoxic episode may cause cancer cell death before resistance to a hypoxic environment develops. CO exposure before a clinical breast cancer diagnosis may therefore have affected precancerous or existing cancer cells in patients who experienced CO poisoning.
Potential Therapeutic Effects of Carbon Monoxide
CO maintains cellular and tissue homeostasis through antiapoptotic (inhibiting programmed cell death), anti-inflammatory and antioxidant effects. It also has antiproliferative (inhibiting proliferation) and vasodilatory effects and may contribute to strengthening innate immunity. CO also has therapeutic applications, but its potential toxicity through effects on oxygen transport and control of the toxic dose during systemic administration of CO gas are major concerns. CO poisoning can cause hypoxia and inflammation, followed by neurological and cardiac dysfunction, damage to other organs and even death.
In recent years, CORMs, a group of CO-releasing transition-metal carbonyls or boranocarbonates, have provided a new route for CO administration. High CO concentrations exert cytotoxic (cell-killing) effects through inhibition of mitochondrial respiration, induction of oxidative stress and production of reactive oxygen species. CORMs may allow localized release of large amounts of CO for specific cytotoxicity against targeted tumors.
One study found that treatment with RuCO, a type of CORM, reduced the growth of human MCF7 and MDA-MB-231 breast cancer cells. Another study found that manganese carbonyl complexes, a CO-releasing photo-CORM, destroyed breast cancer cells in a dose-dependent manner and that a particular concentration killed approximately 40% of the breast cancer cells.
Along with CORMs, CO's anticancer potential against pancreatic cancer and lung adenocarcinoma is also coming to the fore.
Conclusion
The Taiwanese study of breast cancer risk in women with and without CO poisoning, together with studies of CO's effects on the cancer microenvironment, cellular pathways and other areas, suggests a relationship between CO and cancer. However, its toxic effects limit its therapeutic use. As the studies also note, each aspect of CO's relationship with these topics requires far more detailed investigation.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.